New Drugs & OTCs

04/05/2011 - 11:24am
Viramune XR approved by the FDA

The Food and Drug Administration has approved Boehringer Ingelheim Pharmaceuticals' single-pill antiretroviral for HIV-1 patients, BI said Tuesday.

04/05/2011 - 11:00am
Takeda tries to block Impax's launch of generic Dexilant

Generic drug maker Impax Labs is hoping to become the first to market a version of a gastroesophageal reflux disease treatment made by Takeda Pharmaceutical.

04/05/2011 - 10:20am
Bioniche Pharma launches generic Sandostatin

Mylan subsidiary Bioniche Pharma has launched an injectable treatment for a rare metabolic disorder, Mylan said Tuesday.

04/04/2011 - 12:49pm
Lilly launches Axiron

A topical medication for treating low testosterone in men now is available, drug maker Eli Lilly said.

04/04/2011 - 11:47am
PL Developments to sell, distribute store-brand generic Zegerid OTC

PL Developments on Monday announced that it has acquired the exclusive rights to sell and distribute store-brand over-the-counter versions of omeprazole sodium bicarbonate capsules, the generic version of Merck’s Zegerid OTC.

04/04/2011 - 11:25am
ProStrakan announces U.S. launch of Abstral

A drug used to treat pain in cancer patients now is available in the United States.

04/04/2011 - 10:47am
New Cardinal Health toolkit helps independent pharmacists with social media outreach

Cardinal Health on Monday released the independent pharmacist’s social media toolkit, available exclusively to its independent retail pharmacy customers in recognition of the fundamental change in how independent pharmacies interact today with their patients and market their businesses.

04/04/2011 - 10:27am
Mylan's generic Xalatan receives regulatory approval

The Food and Drug Administration has approved a generic drug made by Mylan that reduces pressure in the eye, Mylan said Monday.

04/01/2011 - 10:35am
Watson receives FDA approval for Nulecit

The Food and Drug Administration has approved a generic treatment for iron deficiency anemia made by Watson Pharmaceuticals, Watson said Thursday.

03/31/2011 - 12:04pm
FDA OKs continued compounding of versions of Makena

Usually, when the Food and Drug Administration approves a commercial version of a drug, it prohibits compounding pharmacies from producing it, but it’s making an exception in the case of a drug used to prevent premature births.

© 2013 Drug Store News. All Rights Reserved.